Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vsWest Pharmaceutical Services Inc (WST)
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$1.69
-11.05%
HEALTHCARE · Cap: $13.94M
WST
West Pharmaceutical Services Inc
$366.00
+0.75%
HEALTHCARE · Cap: $25.69B
Smart Verdict
WallStSmart Research — data-driven comparison
West Pharmaceutical Services Inc generates 6668170% more annual revenue ($3.33B vs $49,890). WST leads profitability with a 17.0% profit margin vs 0.0%. WST earns a higher WallStSmart Score of 59/100 (C).
CUPR
Avoid25
out of 100
Grade: F
WST
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CUPR.
Margin of Safety
-44.6%
Fair Value
$170.28
Current Price
$366.00
$195.72 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 267.4% year-over-year
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Strong operational efficiency at 22.5%
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -92.4% — below average capital efficiency
Trading at 8.6x book value
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : CUPR
The strongest argument for CUPR centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 267.4% demonstrates continued momentum.
Bull Case : WST
The strongest argument for WST centers on Altman Z-Score, Debt/Equity, Operating Margin. Profitability is solid with margins at 17.0% and operating margin at 22.5%. Revenue growth of 13.8% demonstrates continued momentum.
Bear Case : CUPR
The primary concerns for CUPR are EPS Growth, Market Cap, Profit Margin.
Bear Case : WST
The primary concerns for WST are Price/Book, PEG Ratio, P/E Ratio. A P/E of 46.8x leaves little room for execution misses.
Key Dynamics to Monitor
CUPR profiles as a hypergrowth stock while WST is a mature play — different risk/reward profiles.
CUPR is growing revenue faster at 267.4% — sustainability is the question.
WST generates stronger free cash flow (81M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
WST scores higher overall (59/100 vs 25/100), backed by strong 17.0% margins and 13.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?